These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 21631494

  • 1. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.
    Cady RK, Goldstein J, Nett R, Mitchell R, Beach ME, Browning R.
    Headache; 2011; 51(7):1078-86. PubMed ID: 21631494
    [Abstract] [Full Text] [Related]

  • 2. Gelstat Migraine (sublingually administered feverfew and ginger compound) for acute treatment of migraine when administered during the mild pain phase.
    Cady RK, Schreiber CP, Beach ME, Hart CC.
    Med Sci Monit; 2005 Sep; 11(9):PI65-9. PubMed ID: 16127373
    [Abstract] [Full Text] [Related]

  • 3. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
    Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH, Investigators.
    Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
    [Abstract] [Full Text] [Related]

  • 4. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB, Munjal S, Brand-Schieber E, Rapoport AM.
    Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
    [Abstract] [Full Text] [Related]

  • 5. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R, O'Carroll P, Dexter K, Freitag F, Shade CL.
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M, Hee A, Emeribe U, Silberstein S.
    CNS Drugs; 2006 Jan; 20(12):1019-26. PubMed ID: 17140280
    [Abstract] [Full Text] [Related]

  • 7. Sublingual feverfew/ginger (LipiGesic M) reanalysis of data.
    Cady R, Serrano D, Lipton R, Browning R.
    Headache; 2013 Feb; 53(2):384-6. PubMed ID: 23432446
    [No Abstract] [Full Text] [Related]

  • 8. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M.
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [Abstract] [Full Text] [Related]

  • 9. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003 Apr; 17(9):653-67. PubMed ID: 12828501
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials.
    Lipton RB, Stewart WF, Ryan RE, Saper J, Silberstein S, Sheftell F.
    Arch Neurol; 1998 Feb; 55(2):210-7. PubMed ID: 9482363
    [Abstract] [Full Text] [Related]

  • 11. Double-blind placebo-controlled randomized clinical trial of ginger ( Zingiber officinale Rosc.) addition in migraine acute treatment.
    Martins LB, Rodrigues AMDS, Rodrigues DF, Dos Santos LC, Teixeira AL, Ferreira AVM.
    Cephalalgia; 2019 Jan; 39(1):68-76. PubMed ID: 29768938
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks.
    Tepper SJ, Vasudeva R, Krege JH, Rathmann SS, Doty E, Vargas BB, Magis D, Komori M.
    Headache; 2020 Sep; 60(8):1601-1615. PubMed ID: 32634275
    [Abstract] [Full Text] [Related]

  • 13. Double-blind placebo-controlled randomized clinical trial of ginger (Zingiber officinale Rosc.) in the prophylactic treatment of migraine.
    Martins LB, Rodrigues AMDS, Monteze NM, Tibaes JRB, Amaral MHA, Gomez RS, Teixeira AL, Ferreira AVM.
    Cephalalgia; 2020 Jan; 40(1):88-95. PubMed ID: 31398997
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).
    Cady RK, McAllister PJ, Spierings EL, Messina J, Carothers J, Djupesland PG, Mahmoud RA.
    Headache; 2015 Jan; 55(1):88-100. PubMed ID: 25355310
    [Abstract] [Full Text] [Related]

  • 15. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.
    Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH.
    Cephalalgia; 2005 Nov; 25(11):1031-41. PubMed ID: 16232154
    [Abstract] [Full Text] [Related]

  • 17. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L.
    CNS Drugs; 2005 Nov; 19(2):125-36. PubMed ID: 15697326
    [Abstract] [Full Text] [Related]

  • 18. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.
    Silberstein S, Winner PK, McAllister PJ, Tepper SJ, Halker R, Mahmoud RA, Siffert J.
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [Abstract] [Full Text] [Related]

  • 19. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.
    Maizels M, Blumenfeld A, Burchette R.
    Headache; 2004 Oct; 44(9):885-90. PubMed ID: 15447697
    [Abstract] [Full Text] [Related]

  • 20. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH, Winner P, Strohmaier K, Klipfel M, Peng Y, McCarroll K, Cady R, Lewis D, Nett R, Rizatriptan Protocol 059 and 061 Study Groups.
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.